Agenus (AGEN) Return on Capital Employed (2011 - 2026)
Agenus' (AGEN) quarterly Return on Capital Employed came in at 19.23% in Q1 2026, up 202667.0% year-on-year from N/an in Q1 2025, and down 188.83% quarter-over-quarter from 21.65% in Q4 2025.
Agenus (AGEN) Return on Capital Employed (2011 - 2026) Analysis & Trends
Agenus' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 19.23% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 202667.0% year-over-year to 19.23% in Q1 2026; TTM through Mar 2026 was 19.23%, a 202667.0% increase from a year earlier, with the FY2025 full-year figure at 20.8%, up 26823.0% from the prior year.
- Return on Capital Employed declined to 19.23% in Q1 2026 per AGEN's latest filing, from 21.65% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 21.65% in Q4 2025 and bottomed at 2973.49% in Q2 2024.
- The 5-year median for Return on Capital Employed is 52.78% (2023), against an average of 428.5%.
- Across the five-year window, Return on Capital Employed slumped 292071 bps in 2024 and jumped 292738 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 42.95% in 2022, then sank by 440 bps to 231.92% in 2023, then plunged by 373 bps to 1097.67% in 2024, then surged by 102 bps to 21.65% in 2025, then plunged by 189 bps to 19.23% in 2026.
- Per Business Quant, the three latest AGEN Return on Capital Employed figures stand at 19.23% (Q1 2026), 21.65% (Q4 2025), and 28.94% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | -19.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.23% |
| Dec 31, 2025 | 21.65% |
| Sep 30, 2025 | -28.94% |
| Jun 30, 2025 | -46.11% |
| Mar 31, 2025 | -2,045.90% |
| Dec 31, 2024 | -1,097.67% |
| Sep 30, 2024 | -37.64% |
| Jun 30, 2024 | -2,973.49% |
| Mar 31, 2024 | -472.36% |
| Dec 31, 2023 | -231.92% |
| Sep 30, 2023 | -132.22% |
| Jun 30, 2023 | -52.78% |
| Mar 31, 2023 | -89.20% |
| Dec 31, 2022 | -42.95% |
| Sep 30, 2022 | -65.19% |
| Jun 30, 2022 | 18.51% |
| Mar 31, 2022 | 10.89% |
| Dec 31, 2021 | 8.73% |
| Sep 30, 2021 | 35.23% |
| Jun 30, 2021 | -366.23% |